Biotech Growth Trust (The) (LSE:BIOG) Capex-to-Revenue : 0.00 (As of Mar. 2024)

Biotech Growth Trust (The) Capex-to-Revenue Chart

Biotech Growth Trust (The) Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Capex-to-Revenue		Get a 7-Day Free Trial					-	-	-	-	-

Biotech Growth Trust (The) Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Capex-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Biotech Growth Trust (The)'s Capex-to-Revenue

For the Asset Management subindustry, Biotech Growth Trust (The)'s Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotech Growth Trust (The)'s Capex-to-Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biotech Growth Trust (The)'s Capex-to-Revenue falls into.

Biotech Growth Trust (The) Capex-to-Revenue Calculation

Biotech Growth Trust (The)'s Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Biotech Growth Trust (The)'s Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotech Growth Trust (The)  (LSE:BIOG) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Biotech Growth Trust (The) Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Growth Trust (The) (LSE:BIOG) Business Description